Atsena Therapeutics has received EMA orphan designation for two gene [...]

VIVEbiotech has expanded its in vivo lentiviral vector portfolio to [...]

Chiesi Global Rare Diseases has launched the second edition of [...]

Allucent has appointed new therapeutic strategy leaders across key disease [...]

Cereno Scientific has reported initial long-term safety findings from a [...]

A new global initiative aims to address long-standing limitations in [...]

UMass Chan Medical School, Caring Cross and Trenchant BioSystems have [...]

BridgeBio Pharma has submitted a New Drug Application (NDA) to [...]

Chiesi Global Rare Diseases has received a positive CHMP opinion [...]

Hansa Biopharma’s Biologics License Application (BLA) for imlifidase has been [...]